Skip to main navigation Skip to search Skip to main content

Erratum: Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia (The Pharmacogenomics Journal, (2016), 16, 6, (530-535), 10.1038/tpj.2015.63)

  • M. Krajinovic
  • , J. Elbared
  • , S. Drouin
  • , L. Bertout
  • , A. Rezgui
  • , M. Ansari
  • , M. J. Raboisson
  • , S. E. Lipshultz
  • , L. B. Silverman
  • , S. E. Sallan
  • , D. S. Neuberg
  • , J. L. Kutok
  • , C. Laverdière
  • , D. Sinnett
  • , G. Andelfinger

Research output: Contribution to journalComment/debate

7 Scopus citations

Abstract

Correction to: The Pharmacogenomics Journal (2016) 16: 530-535; doi:10.1038/tpj.2015.63 In the published version of this article, some funding sources were omitted in the Acknowledgments section. The correct Acknowledgments appears below. The authors regret the error.

Original languageEnglish
Pages (from-to)107
Number of pages1
JournalPharmacogenomics Journal
Volume17
Issue number1
DOIs
StatePublished - Jan 2017

Fingerprint

Dive into the research topics of 'Erratum: Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia (The Pharmacogenomics Journal, (2016), 16, 6, (530-535), 10.1038/tpj.2015.63)'. Together they form a unique fingerprint.

Cite this